Ask AI

Myeloma Myth Busters: Investigating the Now, Soon, and Future Clinical Implications of CELMoD Agents

Enhance your knowledge of CELMoD agents by reviewing mechanistic aspects of these novel therapeutics and key clinical trial data across the disease continuum of multiple myeloma through a podcast, certified on-demand webcast, expert-written ClinicalThought commentary, and accompanying downloadable slides.

Share

Program Content

Events

Activities

CELMoD Agent Trial Data in MM
CELMoD Agents in Maintenance and Early-Relapse Settings for Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb